DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20213480

Comparative study of efficacy and safety of intravenous ferric carboxymaltose versus iron sucrose in treatment of post-partum anemia

Jayanthy T., Ragvi Raman, Apoorva Asranna

Abstract


Background: Ferric carboxymaltose has been recently introduced for the treatment of anaemia. The present study was planned to compare the efficacy, tolerability and safety of intravenous ferric carboxymaltose with intravenous iron sucrose in the treatment of iron deficiency anaemia among postpartum women.

Methods: A total of 60 postpartum women with haemoglobin levels between 7-10 g/dl were randomized into two groups: 30 in group A (received iron carboxymaltose) and 30 in group B (Received iron sucrose). Haemoglobin and serum ferritin levels were done on day 0 and after 6 weeks.

Results: The post treatment haemoglobin levels were found to be 10-10.9 g/dl in 66.7% of women in group A and 63.3% in group B. The mean post treatment haemoglobin levels in group A was 9.97±0.3 g/dl and in group B was 10.9 g/dl (p<0.001). The mean increase in haemoglobin levels post treatment were significantly high in group B (2.1±0.5 gm%) compared to group A (1.3±0.5 gm%). The mean post treatment S. Ferritin levels in group A was 91.2±25.8 and in group B was 126.5±23.2 gm%. The mean increase in S. Ferritin levels post treatment were significantly high in group B (96.9±23.3) compared to group A (62.7±22.6) (p<0.001).

Conclusions: Intravenous iron carboxymaltose is more effective and better tolerated in the treatment of iron deficiency anaemia among postpartum women compared to intravenous iron sucrose.


Keywords


Intravenous iron sucrose, Iron carboxymaltose, Postpartum anaemia, Haemoglobin, Serum ferritin

Full Text:

PDF

References


World Health Organization. The prevalence of anaemia in women: a tabulation of available information. World Health Organization. 1992. Available at: http://apps.who.int/iris/bitstream/ handle/10665/58994/WHO_MCH_MSM_92.2.pdf?sequence=1. Accessed on 15 July 2021.

World Health Organization, World Health Organization. Reproductive Health, World Health Organization. Department of Reproductive Health. Pregnancy, childbirth, postpartum, and new born care: a guide for essential practice. World Health Organization. 2003. Available at: https://www.afro.who.int/sites/default/files/2017-06/mps%20pcpnc.pdf. Accessed on 15 July 2021.

Perez EM, Hendricks MK, Beard JL, Murray-Kolb LE, Berg A, Tomlinson M et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anaemia. The Journal of nutrition. 2005;135(4):850-5.

Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency?. American journal of obstetrics and gynaecology. 2005;193(1):36-44.

Brindley PL, Dalenius K, Grummer-Strawn L, Reinold CM, Smith BL. Division of Nutrition, Physical Activity, and Obesity. National Center for Chronic Disease Prevention and Health Promotion. Centers for Disease Control and Prevention. Pregnancy nutrition surveillance. 2007.

Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Annals of haematology. 2011;90(11):1247-53.

Verdon F, Burnand B, Stubi CF, Bonard C, Graff M, Michaud A et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. Bmj. 2003;326(7399):1124.

Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. The Journal of nutrition. 2005;135(2):267-72.

Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: An International Journal of Obstetrics & Gynaecology. 2006;113(11):1248-52.

Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: An International Journal of Obstetrics & Gynaecology. 2006;113(11):1248-52.

Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron–sucrose complex. British journal of nutrition. 2002;88(1):3-10.

Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American journal of obstetrics and gynaecology. 2008;199(4):435-e1.

Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynaecology & Obstetrics. 2008;101(1):67-73.

Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, Kriplani A. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy-randomised controlled trial. BMC pregnancy and childbirth. 2019;19(1):1-8.

Giannoulis C, Daniilidis A, Tantanasis T, Dinas K, Tzafettas J. Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia. 2009;13(1):38-40.

Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynecology and Obstetrics. 2008;101(1):67-73.